Go Pro

MarketBeat Instant News Alerts

Chime Financial logo with Finance background

Chime Financial (NASDAQ:CHYM) Stock Price Expected to Rise, Barclays Analyst Says

Barclays lifted their price objective on Chime Financial from $33.00 to $40.00 and gave the company an "overweight" rating in a research note on Wednesday.

NASDAQ:CHYM
Read Chime Financial (NASDAQ:CHYM) Stock Price Expected to Rise, Barclays Analyst Says
Oracle logo with Technology background

Oracle (NYSE:ORCL) Given "Market Outperform" Rating at Citizens Jmp

Citizens Jmp restated a "market outperform" rating and set a $285.00 price objective on shares of Oracle in a report on Wednesday.

NYSE:ORCL
Read Oracle (NYSE:ORCL) Given "Market Outperform" Rating at Citizens Jmp
Structure Therapeutics logo with Healthcare background

Structure Therapeutics (NASDAQ:GPCR) Earns "Market Outperform" Rating from Citizens Jmp

Citizens Jmp reissued a "market outperform" rating and issued a $110.00 price target on shares of Structure Therapeutics in a report on Wednesday.

NASDAQ:GPCR
Read Structure Therapeutics (NASDAQ:GPCR) Earns "Market Outperform" Rating from Citizens Jmp
lululemon athletica logo with Consumer Discretionary background

lululemon athletica (NASDAQ:LULU) Now Covered by BMO Capital Markets

BMO Capital Markets began coverage on lululemon athletica in a report on Wednesday. They set an "underperform" rating and a $70.00 price target on the stock.

NASDAQ:LULU
Read lululemon athletica (NASDAQ:LULU) Now Covered by BMO Capital Markets
Intellia Therapeutics logo with Healthcare background

Intellia Therapeutics' (NTLA) Market Outperform Rating Reiterated at Citizens Jmp

Citizens Jmp reiterated a "market outperform" rating and issued a $30.00 price target on shares of Intellia Therapeutics in a research note on Wednesday.

NASDAQ:NTLA
Read Intellia Therapeutics' (NTLA) Market Outperform Rating Reiterated at Citizens Jmp
Pharvaris logo with Healthcare background

Citizens Jmp Issues Positive Forecast for Pharvaris (NASDAQ:PHVS) Stock Price

Citizens Jmp raised their price target on shares of Pharvaris from $75.00 to $79.00 and gave the stock a "market outperform" rating in a research note on Wednesday.

NASDAQ:PHVS
Read Citizens Jmp Issues Positive Forecast for Pharvaris (NASDAQ:PHVS) Stock Price

Trending News

All MarketBeat Instant News Alerts

Optical Cable logo with Technology background

Optical Cable (NASDAQ:OCC) Issues Earnings Results

NASDAQ:OCC
Read Optical Cable (NASDAQ:OCC) Issues Earnings Results
Bankwell Financial Group logo with Finance background

Bankwell Financial Group (NASDAQ:BWFG) Director Jeffrey Dunne Acquires 261 Shares

NASDAQ:BWFG
Read Bankwell Financial Group (NASDAQ:BWFG) Director Jeffrey Dunne Acquires 261 Shares
Bankwell Financial Group logo with Finance background

Carl Porto Buys 327 Shares of Bankwell Financial Group (NASDAQ:BWFG) Stock

NASDAQ:BWFG
Read Carl Porto Buys 327 Shares of Bankwell Financial Group (NASDAQ:BWFG) Stock
Bankwell Financial Group logo with Finance background

Eric Dale Purchases 530 Shares of Bankwell Financial Group (NASDAQ:BWFG) Stock

NASDAQ:BWFG
Read Eric Dale Purchases 530 Shares of Bankwell Financial Group (NASDAQ:BWFG) Stock
Figure Technology Solutions logo with Finance background

Figure Technology Solutions (NASDAQ:FIGR) Upgraded by Bank of America to "Neutral" Rating

NASDAQ:FIGR
Read Figure Technology Solutions (NASDAQ:FIGR) Upgraded by Bank of America to "Neutral" Rating
Sasol logo with Materials background

Sasol (NYSE:SSL) Upgraded to Buy at Bank of America

NYSE:SSL
Read Sasol (NYSE:SSL) Upgraded to Buy at Bank of America
Dyne Therapeutics logo with Healthcare background

JPMorgan Chase & Co. Downgrades Dyne Therapeutics (NASDAQ:DYN) to Underweight

NASDAQ:DYN
Read JPMorgan Chase & Co. Downgrades Dyne Therapeutics (NASDAQ:DYN) to Underweight
Patria Investments logo with Finance background

Patria Investments (NYSE:PAX) Rating Lowered to Underperform at Bank of America

NYSE:PAX
Read Patria Investments (NYSE:PAX) Rating Lowered to Underperform at Bank of America
ANI Pharmaceuticals logo with Healthcare background

ANI Pharmaceuticals (NASDAQ:ANIP) Earns Outperform Rating from Analysts at Leerink Partners

NASDAQ:ANIP
Read ANI Pharmaceuticals (NASDAQ:ANIP) Earns Outperform Rating from Analysts at Leerink Partners
Avantor logo with Healthcare background

Avantor (NYSE:AVTR) Earns Neutral Rating from Analysts at UBS Group

NYSE:AVTR
Read Avantor (NYSE:AVTR) Earns Neutral Rating from Analysts at UBS Group
Better Home & Finance logo with Finance background

B. Riley Financial Begins Coverage on Better Home & Finance (NASDAQ:BETR)

NASDAQ:BETR
Read B. Riley Financial Begins Coverage on Better Home & Finance (NASDAQ:BETR)
Bruker logo with Healthcare background

UBS Group Begins Coverage on Bruker (NASDAQ:BRKR)

NASDAQ:BRKR
Read UBS Group Begins Coverage on Bruker (NASDAQ:BRKR)
Collegium Pharmaceutical logo with Healthcare background

Collegium Pharmaceutical (NASDAQ:COLL) Earns Outperform Rating from Analysts at Leerink Partners

NASDAQ:COLL
Read Collegium Pharmaceutical (NASDAQ:COLL) Earns Outperform Rating from Analysts at Leerink Partners
FuelCell Energy logo with Industrials background

FuelCell Energy (NASDAQ:FCEL) Earns Buy Rating from Analysts at Craig Hallum

NASDAQ:FCEL
Read FuelCell Energy (NASDAQ:FCEL) Earns Buy Rating from Analysts at Craig Hallum
Stevanato Group logo with Healthcare background

Stevanato Group (NYSE:STVN) Coverage Initiated at UBS Group

NYSE:STVN
Read Stevanato Group (NYSE:STVN) Coverage Initiated at UBS Group
Tempus AI logo with Healthcare background

Tempus AI (NASDAQ:TEM) Now Covered by Analysts at UBS Group

NASDAQ:TEM
Read Tempus AI (NASDAQ:TEM) Now Covered by Analysts at UBS Group
Twist Bioscience logo with Healthcare background

Twist Bioscience (NASDAQ:TWST) Now Covered by UBS Group

NASDAQ:TWST
Read Twist Bioscience (NASDAQ:TWST) Now Covered by UBS Group
ServiceTitan logo with Technology background

BMO Capital Markets Cuts ServiceTitan (NASDAQ:TTAN) Price Target to $90.00

NASDAQ:TTAN
Read BMO Capital Markets Cuts ServiceTitan (NASDAQ:TTAN) Price Target to $90.00
eBay logo with Consumer Discretionary background

eBay Sees Collectibles, Live Commerce and AI Powering Its Next Growth Phase

NASDAQ:EBAY
Read eBay Sees Collectibles, Live Commerce and AI Powering Its Next Growth Phase
InnovAge logo with Healthcare background

InnovAge (NASDAQ:INNV) Given New $14.00 Price Target at KeyCorp

NASDAQ:INNV
Read InnovAge (NASDAQ:INNV) Given New $14.00 Price Target at KeyCorp
ServiceTitan logo with Technology background

KeyCorp Lowers ServiceTitan (NASDAQ:TTAN) Price Target to $110.00

NASDAQ:TTAN
Read KeyCorp Lowers ServiceTitan (NASDAQ:TTAN) Price Target to $110.00
enGene logo with Healthcare background

enGene (NASDAQ:ENGN) Receives Market Perform Rating from Citizens Jmp

NASDAQ:ENGN
Read enGene (NASDAQ:ENGN) Receives Market Perform Rating from Citizens Jmp
Opus Genetics logo with Healthcare background

Chardan Capital Reaffirms "Buy" Rating for Opus Genetics (NASDAQ:IRD)

NASDAQ:IRD
Read Chardan Capital Reaffirms "Buy" Rating for Opus Genetics (NASDAQ:IRD)
Chime Financial logo with Finance background

KeyCorp Forecasts Strong Price Appreciation for Chime Financial (NASDAQ:CHYM) Stock

NASDAQ:CHYM
Read KeyCorp Forecasts Strong Price Appreciation for Chime Financial (NASDAQ:CHYM) Stock

Featured Articles and Offers

Alert Categories

All Alerts